temozolomide has been researched along with transforming growth factor beta in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kokkinakis, DM; Liu, X; Neuner, RD | 1 |
| Frank, B; Möhle, R; Tabatabai, G; Weller, M; Wick, W | 1 |
| da Fonseca, CO; Fischer, J; Futuro, D; Gattass, CR; Nagel, J; Quirico-Santos, T; Schwartsmann, G | 1 |
| Fang, W; Hu, Z; Li, Z; Liu, Z; Long, H; Peng, Y; Qi, S; Que, T; Song, Y; Wang, G; Yi, L; Zhang, X; Zheng, S | 1 |
| Abate, F; Blumberg, AJ; Cazzato, E; Elliott, O; Eoli, M; Finocchiaro, G; Frattini, V; Iavarone, A; Ladewig, E; Lasorella, A; Lee, IH; Lee, JK; Liu, Z; Nam, DH; Park, WY; Rabadan, R; Rosenbloom, DI; Shin, YJ; Wang, J; Zairis, S | 1 |
| Chen, L; Hu, Z; Huang, A; Li, H; Li, J; Lu, Y; Ma, L; Qi, S; Shi, L; Weng, Z; Xin, Z; Yu, S; Zhou, Q | 1 |
| Bredel, M; Celebre, A; Chuang, JH; Das, S; Graham, MS; Johnson, K; Karamchandani, J; Kessler, JA; Kim, H; Sachdeva, R; Shahzad, U; Verhaak, R; Wu, M | 1 |
1 trial(s) available for temozolomide and transforming growth factor beta
| Article | Year |
|---|---|
Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas.
Topics: Administration, Intranasal; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Blood-Brain Barrier; Brain Neoplasms; Dacarbazine; Disease Progression; Drug Administration Schedule; Enzyme Inhibitors; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Monoterpenes; Neoplasm Recurrence, Local; Oncogene Protein p21(ras); Signal Transduction; Survival Rate; Temozolomide; Transforming Growth Factor beta; Treatment Outcome | 2008 |
6 other study(ies) available for temozolomide and transforming growth factor beta
| Article | Year |
|---|---|
Modulation of cell cycle and gene expression in pancreatic tumor cell lines by methionine deprivation (methionine stress): implications to the therapy of pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Blotting, Western; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Dacarbazine; Fluorouracil; Gene Expression; Gene Expression Profiling; Humans; Methionine; Neoplasm Proteins; O(6)-Methylguanine-DNA Methyltransferase; Oligonucleotide Array Sequence Analysis; Pancreatic Neoplasms; Phosphorylation; Retinoblastoma Protein; Signal Transduction; Temozolomide; Transforming Growth Factor beta | 2005 |
Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-beta-dependent HIF-1alpha-mediated induction of CXCL12.
Topics: Animals; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Chemokines, CXC; Dacarbazine; Gamma Rays; Glioma; Hematopoietic Stem Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Mice; Mice, Nude; Neoplasm Proteins; Promoter Regions, Genetic; Signal Transduction; Temozolomide; Transcription, Genetic; Transforming Growth Factor beta | 2006 |
A complex mechanism for HDGF-mediated cell growth, migration, invasion, and TMZ chemosensitivity in glioma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Cadherins; Carcinogenesis; Cell Line, Tumor; Cell Movement; Child; Dacarbazine; Epithelial-Mesenchymal Transition; Female; Glioma; Humans; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Proto-Oncogene Proteins c-akt; Signal Transduction; Temozolomide; Transforming Growth Factor beta; Young Adult | 2014 |
Clonal evolution of glioblastoma under therapy.
Topics: Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Brain Neoplasms; Cell Proliferation; Clonal Evolution; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Gene Expression Regulation, Neoplastic; Genomics; Glioblastoma; Humans; Isocitrate Dehydrogenase; Latent TGF-beta Binding Proteins; Longitudinal Studies; Mutation; Neoplasm Grading; Neoplasm Recurrence, Local; Survival Rate; Temozolomide; Transcriptome; Transforming Growth Factor beta; Tumor Suppressor Proteins | 2016 |
HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma.
Topics: Animals; Antineoplastic Agents, Alkylating; Autophagy; Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Glioblastoma; HEK293 Cells; Humans; Mice; Mice, Nude; Prognosis; Proteolysis; Signal Transduction; Smad7 Protein; Survival Rate; Temozolomide; Transforming Growth Factor beta; Ubiquitin-Protein Ligases; Ubiquitination; Xenograft Model Antitumor Assays | 2019 |
BMP signaling mediates glioma stem cell quiescence and confers treatment resistance in glioblastoma.
Topics: Animals; Antineoplastic Agents; Bone Morphogenetic Protein 4; Bone Morphogenetic Proteins; Brain Neoplasms; Cell Division; Cell Line, Tumor; Cell Proliferation; Disease Progression; Drug Resistance, Neoplasm; Glioblastoma; Glioma; Homeostasis; Humans; Mice; Mice, Inbred NOD; Neoplasm Recurrence, Local; Neoplasm Transplantation; Neoplastic Stem Cells; Phenotype; RNA, Small Interfering; Sequence Analysis, RNA; Signal Transduction; Temozolomide; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2019 |